Holley ( ($HLLY) ) has shared an update. On December 10, 2025, Holley Inc. amended the employment agreement with its President and CEO, Matthew Ste......

The pharma giant has high hopes for the medication. ...

In a report released yesterday, Mohit Bansal from Wells Fargo maintained a Buy rating on Eli Lilly & Co, with a price target of $1,200.00. Bansal c......

The obesity treatment space has been generating plenty of headlines – and sales – over the past few years. GLP-1 receptor agonists such as semaglut......

Earnings reports, analyst updates, and other economic news are among the top stock market stories for Wednesday. ...

The pharma giant is racing to bring a weight-loss pill to market. ...

Hims & Hers Health ($HIMS) is strengthening its position in the UK with the launch of weight-loss programs. This launch will also include the offic......

Biotech Structure Therapeutics’ ($GPCR) shares rallied 102.49% on Monday after mid-stage data for its obesity pill topped competing offerings from ......

The award-winning researcher was previously at Eli Lilly from 2017-2021. ...

Shares of Texas-based biotech firm iBio ($IBIO) have climbed as high as 50% over the past 24 hours. This follows a 39.17% gain on Monday and an add......